Results 191 to 200 of about 101,499 (309)

Mapping malignant T‐cell states and immune circuits in Sézary syndrome by single‐cell analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Peripheral blood single‐cell RNA‐seq from leukaemic CTCL defined three malignant T‐cell programmes: MTC CM, MTC Reg and MTC E/EM, each with distinct features and candidate vulnerabilities. For example, inferred immune circuits highlighted actionable IL‐10/JAK–TYK2–STAT3 signalling, KIR–MHC I inhibitory interactions and myeloid/B‐cell inflammatory and ...
Beth A. Childs   +6 more
wiley   +1 more source

Enigmatic Presentation of Primary Cutaneous Lymphoma in a Boy. [PDF]

open access: yesPlast Reconstr Surg Glob Open
Farhan A, Fakhro A, Burshaid D.
europepmc   +1 more source

A retrospective review of cutaneous lymphoma in Botswana. [PDF]

open access: yesInt J Dermatol, 2020
Rodriguez O   +7 more
europepmc   +1 more source

Cutaneous T‐cell lymphomas and dupilumab for atopic dermatitis: A systematic review and expert consensus

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Systematic review (51 studies; 547 patients) indicates dupilumab may unmask/worsen CTCL (mainly MF/SS). A French Delphi consensus recommends rigorous diagnostic workup, avoiding dupilumab in confirmed CTCL, discontinuing upon diagnosis, and favouring methotrexate or phototherapy.
Florent Amatore   +8 more
wiley   +1 more source

Mycosis Fungoides with Dermal Mucin Deposition: An Unusual Variant of the Most Challenging Primary Cutaneous Lymphoma. [PDF]

open access: yesCase Rep Dermatol, 2021
Filosa A   +7 more
europepmc   +1 more source

Medical Phototherapy Malpractice and Legal Precedents in North America (1983–2025)

open access: yes
International Journal of Dermatology, EarlyView.
Ghassan Barnawi   +6 more
wiley   +1 more source

OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta   +4 more
wiley   +1 more source

Granuloma annulare: not as simple as it seems. [PDF]

open access: yes, 2010
Parish, Lawrence Charles   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy